F-1/A: Phaos Technology Enters Research and Development Agreement with MGEN.co.,ltd; Files Amendment No. 1 to Form F-1 for IPO

Phaos Technology Holdings (Cayman) Limited announces a research and development agreement with MGEN.co.,ltd and files an amendment to its Form F-1 registration statement for an initial public offering.

Summary

• Phaos Technology Pte Ltd has entered into a Research and Development Agreement with MGEN.co.,ltd effective January 1st, 2024, to collaborate on a joint project incorporating FIRST TECHNOLOGY and SECOND TECHNOLOGY.
• The agreement, which runs until December 31st, 2026, outlines the responsibilities of both parties in developing a joint research and development product, including adhering to project timelines and milestones.
• The agreement addresses intellectual property rights, with Foreground IP generated solely by one party vesting in that party, and jointly generated IP vesting in both Party A and Party B.
• Party B grants Party A an exclusive, transferable, royalty-free, and perpetual license to use its Background IP and its share of Foreground IP to commercialize the Foreground IP.
• The agreement includes confidentiality clauses that extend for 10 years post-termination.
• Phaos Technology Holdings (Cayman) Limited also filed Amendment No. 1 to its Form F-1 registration statement on February 19, 2025, for an initial public offering of 2,700,000 Class A Ordinary Shares.
• The anticipated IPO price is between US$4.00 and US$5.00 per share, with application made to list on the NYSE American under the symbol POAS.
• The company is authorized to issue an unlimited number of Class A and Class B Ordinary Shares, with each Class A share having one vote and each Class B share having three votes.
• Beh Hook Seng, through TongHuai SG Enterprise Pte. Ltd and TongHuai SG2 Enterprise Pte. Ltd, will control shares representing more than 50% of the total voting power after the offering.
• The underwriter has an option to purchase up to 405,000 additional Class A Ordinary Shares within 45 days to cover any over-allotments.

Sentiment

Score: 7

Explanation: The document presents both positive developments (R&D agreement, IPO plans) and potential risks (concentrated control, reduced reporting requirements). Overall, the sentiment is cautiously optimistic.

Positives

• The Research and Development Agreement with MGEN.co.,ltd could lead to new technological advancements and commercial opportunities.
• The exclusive license granted to Party A for commercializing Foreground IP could provide a significant competitive advantage.
• The IPO will provide capital to fund future growth and expansion initiatives.
• The company has applied to list on the NYSE American which will increase visibility and liquidity.

Negatives

• The dual-class share structure concentrates voting power, potentially limiting the influence of other shareholders.
• The company will be a controlled company under the rules of NYSE American, which may exempt the company from certain corporate governance requirements that could have an adverse effect on public shareholders.

Risks

• The IPO is contingent upon listing approval from the NYSE American, with no assurance of success.
• The concentrated control of voting power by Beh Hook Seng may limit or preclude the ability of other shareholders to influence corporate matters.
• The company is an emerging growth company and a foreign private issuer, which allows for reduced public company reporting requirements, potentially limiting information available to investors.
• The company may lose its foreign private issuer status in the future, which could result in significant additional costs and expenses.

Future Outlook

The company anticipates the initial public offering price of the Class A Ordinary Shares will be between US$[4.00] and US$[5.00] per Class A Ordinary Share and has applied to list its Class A Ordinary Shares on the New York Stock Exchange American (NYSE American) under the symbol [POAS].

Industry Context

The research and development agreement aligns with industry trends of collaboration to drive innovation. The IPO reflects a company's growth ambitions and confidence in its market position.

Comparison to Industry Standards

• The dual-class share structure is similar to that of other technology companies like Google (Alphabet Inc.) and Facebook (Meta Platforms, Inc.), which aim to maintain founder control.
• The IPO size and price range are comparable to other small-cap companies listing on the NYSE American.
• The research and development agreement is similar to other technology companies that partner to develop new technologies.

Stakeholder Impact

• Shareholders: Potential for increased value through IPO and successful R&D.
• Employees: Potential for growth and new opportunities.
• Customers: Potential for innovative products and services.
• Suppliers: Potential for increased business volume.

Next Steps

• Obtain listing approval from the NYSE American.
• Complete the initial public offering.
• Execute the joint research and development project with MGEN.co.,ltd.
• Commercialize the Foreground IP resulting from the joint project.

Key Dates

Keywords

Research and Development Agreement, Initial Public Offering, Intellectual Property, Class A Ordinary Shares, Phaos Technology, MGEN.co.ltd, Foreground IP, Background IP, Confidentiality, NYSE American, Dual-Class Shares, IPO, Shares, Technology, Voting Rights